NFAClass II
Temporary Coronary Saphenous Vein Bypass Graft For Embolic Protection
21 CFR 870.1250 / Cardiovascular
NFA is the FDA product code for Temporary Coronary Saphenous Vein Bypass Graft For Embolic Protection, a class II device type, regulated under 21 CFR 870.1250. As of , FDA records hold 22 510(k) clearances under this code, the most recent dated , and 4 recalls.
Classification record
- Product code
- NFA
- Device name
- Temporary Coronary Saphenous Vein Bypass Graft For Embolic Protection
- Regulation
- 21 CFR 870.1250
- Device class
- Class II
- Review panel
- Cardiovascular
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 22
- Ingested recalls
- 4
Clearances, product code NFA
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2001 | 1 |
| 2002 | 3 |
| 2003 | 3 |
| 2004 | 1 |
| 2005 | 3 |
| 2006 | 8 |
| 2007 | 1 |
| 2008 | 2 |
Applicants with the most clearances
Product code NFA| Applicant | Clearances |
|---|---|
| Medtronic, Inc. | 7 |
| Boston Scientific Corporation | 4 |
| DSM Biomedical, Inc. | 3 |
| Boston Scientific Epi | 2 |
| Medtronic Percusurge, Inc. | 2 |
| Abbott Medical | 2 |
| Percu Surge, Inc. | 1 |
| Velocimed, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
